Cabaletta Bio, Inc. (CABA) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Cabaletta Bio, Inc. on May 15, 2025. The report details a corporate action approved by the Board of Directors regarding the repricing of stock options for employees, directors, and consultants.
Key Financial Metrics
The filing does not provide standard financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The only financial data point disclosed is the new exercise price for repriced options, set at $1.92 per share.
Material Changes
The primary material change is the repricing of "underwater" stock options effective May 19, 2025. Approximately 75% of stock options held by employees, directors, and key consultants were underwater prior to this action. The Board approved reducing the exercise price for eligible options that exceeded 1.5 times the closing stock price on May 19, 2025.
Guidance, Outlook, and Management Commentary
Management stated the repricing was designed to retain and motivate key personnel during a critical stage for the Company. The Board acted in good faith after consulting with independent compensation consultants and legal counsel. No specific financial guidance or outlook was provided in this filing.
Risks and Contingencies
Eligible participants must remain in service through a defined "Retention Period" to exercise options at the reduced price of $1.92. The Retention Period ends on the earliest of: (i) the one-year anniversary of the Effective Date; (ii) a Sale Event; or (iii) termination due to death or disability. If a participant is terminated for cause, resigns, or exercises options before the Retention Period ends, the original higher exercise price applies.
Key Facts for Investor Verification
- Event Date: Option repricing approved May 15, 2025; effective May 19, 2025.
- New Exercise Price: $1.92 per share for eligible underwater options.
- Eligibility: Applies to options with an exercise price exceeding 1.5x the May 19, 2025 closing price.
- Retention Requirement: Participants must remain employed for up to one year to utilize the reduced price.
- Scope: Affects approximately 75% of options held by employees, directors, and consultants.